title: Interferon-alpha suppresses leptin levels: studies in interferon-alpha treated patients with hepatitis C virus infection and murine adipocytes.
abstract: Leptin is an adipocyte-derived protein, which signals the status of current energy stores and energy intake to the central nervous system. Interferon-alpha therapy is frequently associated with loss of appetite and weight reduction. In this study, we tested whether interferon-alpha is able to regulate leptin synthesis. We therefore determined leptin plasma concentrations in thirteen patients with chronic hepatitis C who were treated with 1 x 10(7) IU interferon-alpha daily, up to 21 days after initial treatment. Furthermore, leptin concentrations and messenger RNA levels were quantified in interferon-alpha-treated and untreated murine adipocytes. After reaching peak plasma levels at 12 hours, probably reflecting the circadian rhythm, leptin concentrations fell and were significantly lower after 14 days. They remained significantly decreased 17 and 21 days after the start of the interferon-alpha treatment. In murine adipocytes exposed to interferon-alpha, leptin secretion was significantly decreased while messenger RNA levels remained unchanged. Our data suggest that, in contrast to proinflammatory cytokines such as interleukin-1, interferon-alpha suppresses leptin secretion in adipose tissue. We therefore hypothesize that loss of weight and appetite in interferon-alpha-treated patients with chronic hepatitis C might not be due to an elevation of leptin resulting in signals of increased energy stores in the brain.
authors.affiliation: Department of Medicine, University of Innsbruck, Anichstra e 35, 6020 Innsbruck, Austria.
authors.forename: Susanne
authors.initials: S
authors.lastname: Kaser
authors.forename: Arthur
authors.initials: A
authors.lastname: Kaser
authors.forename: Wolfgang
authors.initials: W
authors.lastname: Vogel
authors.forename: Josef R
authors.initials: JR
authors.lastname: Patsch
authors.forename: Herbert
authors.initials: H
authors.lastname: Tilg
mesh_terms: D016475:3T3 Cells; D017667:Adipocytes / Q000378:metabolism; D000328:Adult; D000818:Animals; D001483:Base Sequence; D017931:DNA Primers; D005260:Female; D019698:Hepatitis C, Chronic / Q000188:drug therapy* / Q000276:immunology; D006801:Humans; D016898:Interferon-alpha / Q000627:therapeutic use*; D020738:Leptin / Q000097:blood / Q000235:genetics* / Q000378:metabolism; D008297:Male; D051379:Mice; D020133:Reverse Transcriptase Polymerase Chain Reaction
chemical_list: D017931:DNA Primers; D016898:Interferon-alpha; D020738:Leptin